Blue Origin clears FAA review, but New Glenn's upper stage keeps raising questions

Blue Origin has received FAA clearance to resume New Glenn launches after an April upper-stage anomaly that left AST SpaceMobile's BlueBird 7 satellite in an unusable orbit and burned up on re-entry. The incident exposes execution risk around Blue Origin's target of up to 12 launches by end-2026, after the company delivered only 2 launches versus an original 6-8 launch plan for 2025. While the booster reuse was a milestone, the upper-stage reliability issue and grounding create schedule pressure for commercial customers such as AST SpaceMobile and Eutelsat.

Analysis

The immediate loser is not just the launch provider’s credibility; it is any satellite operator trying to monetize a tight deployment calendar. A one-month slip looks modest, but in constellation buildouts cadence compounds: one missed slot can cascade into payload integration delays, ground-network activation slippage, and deferred revenue recognition. ASTS is the cleanest near-term expression because its business model is unusually sensitive to launch sequencing, even if the direct hardware loss is insured.

The second-order winner is the incumbent with the highest flight rate and the lowest scheduling variance. Customers do not buy headline reusability; they buy predictability, and every anomaly pushes the market back toward the proven provider’s pricing power. That dynamic should widen the performance gap between “strategic alternative” launch names and the de facto standard over the next 6-12 months, especially for operators with hard launch windows and financing tied to milestone completion.

The market may be underpricing the difference between a recoverable technical issue and a process-quality issue. The bigger risk is not the root cause of one upper-stage thermal event, but whether the stack was too immature to fly commercial payloads this early; if so, the next clean flight still may not restore customer confidence. Conversely, if Blue Origin delivers 2-3 consecutive successful missions, the current skepticism can unwind quickly because launch customers care more about demonstrated cadence than pristine launch histories.

For ASTS, the near-term setup is asymmetric: insurance protects the balance sheet, but not the deployment schedule, so any valuation anchored on 2026 satellite milestones is vulnerable until launch cadence stabilizes. Over the next 1-3 months, expect pressure on suppliers and counterparties whose revenue depends on New Glenn availability, while SpaceX-related share-of-wallet gains should continue in the background. The contrarian view is that this may be more of a schedule hiccup than a structural failure, so outright shorting the launch ecosystem is lower quality than trading relative reliability.

Key Decisions for Investors

• Short ASTS into any rally over the next 2-6 weeks; risk/reward favors downside if launch slippage forces 2026 deployment deferrals, but cover if Blue Origin posts two consecutive clean missions
• Pair trade: long spaceflight/logistics reliability exposure vs short launch-fragility names; if no direct listed vehicle, express via long the most proven commercial-launch beneficiary and short ASTS for a cleaner relative-risk trade
• Avoid initiating new long exposure to Blue Origin-dependent satellite deployment stories until the next 1-2 New Glenn flights clear without payload anomalies; the setup is schedule-risk, not hardware-loss risk
• For longer-dated accounts, buy downside protection on ASTS for the next 3-6 months; insurance removes casualty risk but not timeline risk, so put spreads should outperform outright puts on a favorable rebound
• If New Glenn logs 2-3 clean flights, fade the skepticism in launch-adjacent names and rotate out of short exposure quickly; the upside reversal could be sharp because the market will re-rate cadence faster than engineering maturity